cromolyn sodium 10 MG/ML Inhalation Solution

What the CMS Formulary Data Shows for cromolyn sodium 10 MG/ML Inhalation Solution

Per the CMS 2026 Part D formulary file, cromolyn sodium 10 MG/ML Inhalation Solution (RxNorm concept RXCUI 831246, generic name cromolyn sodium) appears on 330 distinct formulary files spanning 5,067 Medicare Part D plan offerings - 100% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.4.

Real-world access to cromolyn sodium 10 MG/ML Inhalation Solution depends on utilization management as much as tier placement: 99.7% of covering formularies require prior authorization. 0% require step therapy. 0.6% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 37,634 Part D beneficiaries filled cromolyn sodium 10 MG/ML Inhalation Solution in 2023, with total plan-and-beneficiary spending of $9,058,332 and an average per-beneficiary annual cost of $240.70. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry cromolyn sodium 10 MG/ML Inhalation Solution today.